• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Immunological treatment of leukaemias.白血病的免疫治疗
Br Med J. 1970 Nov 21;4(5733):487-8. doi: 10.1136/bmj.4.5733.487.
2
The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.全身免疫佐剂在癌症预防或治疗中的应用。
Johns Hopkins Med J Suppl. 1974;3:85-102.
3
BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
Natl Cancer Inst Monogr. 1973 Dec;39:165-75.
4
Alloimmunization and adoptive immunotherapy of leukemia.白血病的同种免疫和过继性免疫疗法。
Transplant Proc. 1981 Dec;13(4):1910-4.
5
Immunological approaches of leukaemia treatment.
Ann Inst Pasteur (Paris). 1972 Apr;122(4):855-81.
6
Active immunotherapy in the treatment of experimental leukemias and acute lymphoblastic leukemia in man.
Boll Ist Sieroter Milan. 1971 Jul-Aug;50(4):251-9.
7
The immunological aspects of malignant disease.恶性疾病的免疫学方面。
Practitioner. 1975 Apr;214(1282):511-521.
8
The place of immunological methods of treatment in the management of acute leukaemia.免疫治疗方法在急性白血病治疗中的地位。
Hamatol Bluttransfus. 1976;19:297-304. doi: 10.1007/978-3-642-87524-3_31.
9
Prolonged survival in long-passage AKR leukemia using chemotherapy, radiotherapy, and adoptive immunotherapy.使用化疗、放疗和过继性免疫疗法使长期传代的AKR白血病实现长期存活。
Cancer Res. 1974 Aug;34(8):1851-6.
10
Discussion paper: experimental and clinical immunopharmacology data applicable to cancer immunotherapy.讨论文件：适用于癌症免疫治疗的实验和临床免疫药理学数据
Ann N Y Acad Sci. 1976;277(00):467-84. doi: 10.1111/j.1749-6632.1976.tb41721.x.

引用本文的文献

1
Prospects for immunotherapy of cancer: experience in experimental systems.癌症免疫治疗的前景：实验系统中的经验
Br Med J. 1970 Nov 21;4(5733):484-6. doi: 10.1136/bmj.4.5733.484.
2
Evidence for antigenicity in human tumours with reference both to melanoma and acute leukemia.关于黑色素瘤和急性白血病，人类肿瘤中抗原性的证据。
Proc R Soc Med. 1971 Oct;64(10):1044. doi: 10.1177/003591577106401016.
3
Further observations on the effect of C. parvum and anti-tumour globulin on syngeneically transplanted mouse tumours.微小隐孢子虫和抗肿瘤球蛋白对同基因移植小鼠肿瘤影响的进一步观察
Br J Cancer. 1972 Apr;26(2):67-76. doi: 10.1038/bjc.1972.11.
4
Transience of immune responses to tumour antigens in man.人类对肿瘤抗原免疫反应的短暂性。
Br Med J. 1971 Dec 4;4(5787):584-6. doi: 10.1136/bmj.4.5787.584.
5
Eradication of lymphoma cells with allogeneic immune peritoneal cells.用同种异体免疫腹膜细胞清除淋巴瘤细胞。
Experientia. 1973 Apr 15;29(4):479-81. doi: 10.1007/BF01926794.
6
Leukaemia-associated antigens in man. Detection by antibodies in maternal sera.人类白血病相关抗原。通过母体血清中的抗体进行检测。
Clin Exp Immunol. 1974 Aug;17(4):571-86.
7
Histological evidence of tumour rejection after active immunotherapy in human malignant disease.人类恶性疾病主动免疫治疗后肿瘤排斥的组织学证据。
Br Med J. 1972 Apr 22;2(5807):183-8. doi: 10.1136/bmj.2.5807.183.

本文引用的文献

1
[Bone marrow grafts after total irradiation of leukemic mice followed by administration of an antimitotic agent to reduce the incidence of a secondary syndrome and to enhance the antileukemic effect].对白血病小鼠进行全身照射后给予抗有丝分裂剂以降低继发综合征的发生率并增强抗白血病作用后的骨髓移植
C R Hebd Seances Acad Sci. 1962 May 14;254:3603-5.
2
[REDUCTION OF THE PLASMA CONCENTRATION OF THE CHARLOTTE FRIEND LEUKEMOGENIC VIRUS BY ADOPTIVE IMMUNOTHERAPY (GRAFT OF ALLOGENIC BONE MARROW)].通过过继免疫疗法（同种异体骨髓移植）降低夏洛特·弗里德致白血病病毒的血浆浓度
C R Hebd Seances Acad Sci. 1964 Dec 9;259:4408-10.
3
HAEMATOPOIETIC CHIMERA IN MAN AFTER ALLOGENIC (HOMOLOGOUS) BONE-MARROW TRANSPLANTATION. (CONTROL OF THE SECONDARY SYNDROME. SPECIFIC TOLERANCE DUE TO THE CHIMERISM).同种异体（同源）骨髓移植后人类造血嵌合体。（继发性综合征的控制。嵌合导致的特异性耐受）
Br Med J. 1963 Dec 28;2(5373):1633-5. doi: 10.1136/bmj.2.5373.1633.
4
[Local elective immunotherapy of L 1210 ascitic leukemia. Analysis of factors of its efficacy].[L1210腹水型白血病的局部选择性免疫治疗。其疗效影响因素分析]
Eur J Cancer (1965). 1968 May;4(2):211-8. doi: 10.1016/0014-2964(68)90019-4.
5
[Rupture of immune tolerance by total irradiation].[全身照射导致免疫耐受破裂]
Rev Fr Etud Clin Biol. 1968 Dec;13(10):1013-4.
6
The passive immunotherapy of murine leukaemia. I. The production of antisera against leukaemic antigens.小鼠白血病的被动免疫疗法。I. 抗白血病抗原抗血清的制备。
Rev Eur Etud Clin Biol. 1970 Feb;15(2):161-7.
7
Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells.肿瘤细胞移植后应用的L1210白血病主动免疫疗法。
Br J Cancer. 1969 Dec;23(4):814-24. doi: 10.1038/bjc.1969.101.
8
Active immunotherapy for acute lymphoblastic leukaemia.急性淋巴细胞白血病的主动免疫疗法。
Lancet. 1969 Apr 5;1(7597):697-9. doi: 10.1016/s0140-6736(69)92648-8.
9
New antigens in human leukaemic cells and antibody in the serum of leukaemic patients.人类白血病细胞中的新抗原及白血病患者血清中的抗体。
Lancet. 1967 Dec 30;2(7531):1396-8. doi: 10.1016/s0140-6736(67)93027-9.

Immunological treatment of leukaemias.

作者信息

Mathé G

出版信息

Br Med J. 1970 Nov 21;4(5733):487-8. doi: 10.1136/bmj.4.5733.487.

DOI:10.1136/bmj.4.5733.487
PMID:4394735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1820113/
Abstract
摘要